2013		2014		2015		Rate(Cases per 100,000 per month)		Monthly Rate Comparison
Disease	Mar No.	YTD No.	Mar No.	YTD No.	Mar No.	YTD No.	Mar (2010-2014 aggregated)	Mar (2015)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	.	.	.	0	.	0.06	0.00	X
HEPATITIS A	.	.	.	.	0	.	0.06	0.00	X
HEPATITIS B (ACUTE)	5	8	.	.	0	0	0.12	0.00	X
INFLUENZA**	74	455	43	384	27	382	3.82	1.31	X
MEASLES	0	0	0	0	0	9	0.00	0.00
MUMPS	0	0	0	0	0	0	0.00	0.00
PERTUSSIS	.	26	.	16	.	14	0.12	0.10
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
AIDS	20	55	13	46	10	32	0.90	0.48
CHLAMYDIA	735	2215	1760	5048	378	1328	48.93	18.31	X
GONORRHEA	168	535	340	1132	116	433	9.82	5.62	X
HIV	27	62	12	54	20	65	1.04	0.97
SYPHILIS (EARLY LATENT)	22	66	32	142	12	64	0.92	0.58
SYPHILIS (PRIMARY & SECONDARY)	10	29	18	112	10	35	0.52	0.48
ENTERICS
AMEBIASIS	0	.	0	0	0	0	0.03	0.00
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	5	15	8	26	5	16	0.37	0.24
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	.	.	0	.	0	.	0.03	0.00
GIARDIA	.	11	.	6	.	8	0.13	0.05
ROTAVIRUS	13	38	.	7	17	33	0.37	0.82
SALMONELLOSIS	11	29	.	16	.	18	0.41	0.15
SHIGA-TOXIN PRODUCING E. COLI#	.	6	.	.	0	6	0.18	0.00	X
SHIGELLOSIS	.	10	.	5	0	5	0.11	0.00	X
TYPHOID FEVER	0	0	.	.	0	0	0.02	0.00
VIBRIO (NON-CHOLERA)	0	0	0	.	0	0	0.00	0.00
YERSINIOSIS	0	.	0	.	0	0	0.01	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	0	0	0	0.00	0.00
COCCIDIOIDOMYCOSIS	8	15	6	19	.	15	0.35	0.15
DENGUE FEVER	.	.	0	.	0	0	0.01	0.00
ENCEPHALITIS	0	.	0	0	0	0	0.00	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	0	0	0	0	0	0.01	0.00
HEPATITIS C (ACUTE)	0	0	0	0	0	.	0.03	0.00
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.##	0	0	0	0	0	0	0.02	0.00
LEGIONELLOSIS	.	.	0	.	0	5	0.08	0.00	X
LEPROSY (HANSEN’S DISEASE)	0	0	0	0	0	0	0.00	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	.	0	0	0	.	0.00	0.00
LYME DISEASE	0	0	0	0	0	0	0.00	0.00
MALARIA	0	.	0	0	0	0	0.01	0.00
MENINGITIS, ASEPTIC/VIRAL	.	5	6	10	.	5	0.10	0.05
MENINGITIS, BACTERIAL	0	.	.	5	.	.	0.07	0.05
MENINGOCOCCAL DISEASE	0	0	.	.	0	0	0.03	0.00
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	0	0	0	0.00	0.00
Q FEVER	0	0	0	0	0	0	0.00	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	0	0	0	0	0.00	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	219	1077	151	502	93	674	9.25	4.50	X
STREPTOCOCCUS PNEUMONIAE, IPD###	.	20	11	30	10	42	0.28	0.48
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	0	.	.	.	.	.	0.03	0.05
TUBERCULOSIS	9	18	9	12	.	15	0.38	0.19
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.00	0.00

*Rate denominators were spline-interpolated population estimates/projections based on demographic data subject to ongoing revision by the state demographer (last revision as of Oct-2013). Use of onset date to count OOE-reported cases (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect (since Feb-08) cases. HIV/AIDS case counts provided by Office of HIV/AIDS/STD; TB case counts provided by TB clinic. Data suppression denoted by ‘.’ applies if number of cases <5. Monthly disease total reported by OOE=653(reported total=1571). Due to unavailability of current birth data, congenital syphilis rates were not calculated(reported monthly cases [suppression applied] for 2013-2015 were respectively 0,0,0; YTD totals 0,0,0).

**Reporting of novel type A influenza (reclassified as INFLU OUTBRK per CDC recommendations as of Jan-11) started in May-09.

#E. COLI O157:H7 instead of STEC was reported prior to 2006.

##Reported since Mar-07.

###S. pneumo invasive diseases (reported since Sep-05) previouly reported under separate categories grouped together as of Jan-11 per CDC recommendations.

~~Confidence intervals (not shown) for the monthly disease incidence rates provided a basis for an informal statistical test to determine if the current monthly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current month of this year or previous 5 years aggregated).